RIVAROX 15 MG TABLET

RIVAROX 15 MG TABLET contains Rivaroxaban as its active ingredient. Rivaroxaban is classified as a direct oral anticoagulant (DOAC) or a factor Xa inhibitor. It works by inhibiting the activity of factor Xa, an essential component in the blood clotting cascade. This action helps prevent the formation of blood clots and reduces the risk of thrombotic events such as strokes, deep vein thrombosis (DVT), and pulmonary embolism (PE).

Uses:

RIVAROX 15 MG TABLET is prescribed for various medical conditions where there is an increased risk of blood clot formation. It is commonly used for the following purposes:

1. Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
2. Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).
3. Prevention of recurrent DVT and PE after initial treatment.
4. Prophylaxis of venous thromboembolism (VTE) in patients undergoing hip or knee replacement surgery.

Administration:

RIVAROX 15 MG TABLET is typically taken orally with water, once or twice daily, as directed by a healthcare professional. The dosage may vary depending on the medical condition being treated, the patient’s kidney function, and other factors. It is important to follow the prescribed dosage instructions provided by the healthcare provider to achieve optimal anticoagulant effects.

Side Effects:

Common side effects of RIVAROX 15 MG TABLET may include bleeding, bruising, headache, dizziness, gastrointestinal upset (such as nausea, vomiting, or diarrhea), and itching. These side effects are usually mild and temporary. However, if any unusual bleeding or severe side effects occur, such as signs of internal bleeding (e.g., bloody stools, coughing up blood, or unusual bleeding from the gums), immediate medical attention is necessary.

Precautions:

Before using RIVAROX 15 MG TABLET, individuals should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. This medication should be used with caution in patients with a history of bleeding disorders, gastrointestinal ulcers, liver disease, or renal impairment. Regular monitoring of kidney function and blood tests may be necessary during treatment with Rivaroxaban.

Contraindications:

RIVAROX 15 MG TABLET is contraindicated in individuals with a known hypersensitivity or allergy to Rivaroxaban or any of the components of the tablet. It should also be avoided in patients with active pathological bleeding, severe liver disease, or severe renal impairment (creatinine clearance < 15 mL/min). This medication is not recommended for use in pregnant women or individuals with mechanical heart valves.

Conclusion:

RIVAROX 15 MG TABLET, containing Rivaroxaban, is an anticoagulant medication used for various medical conditions associated with an increased risk of blood clot formation. It helps prevent strokes, deep vein thrombosis, pulmonary embolism, and other thrombotic events. Patients prescribed RIVAROX 15 MG TABLET should adhere to their healthcare provider’s instructions and report any unusual bleeding or side effects promptly.